Comparison Contineum Therapeutics (CTNM) with Competitors
Contineum Therapeutics (CTNM) industry is Biotechnology.
Profit Margin
CTNM83.13%
Industry-0.77%
Upside+83.90%
Operating Margin
CTNM77.87%
Industry-2055.25%
Upside+2133.12%
Free Cash Flow Yield
CTNM-10.56%
Industry-1.75%
Upside-8.81%
P/E
CTNM-7.03
Industry-20.52
Upside+1348.25%
P/S
CTNM11.15
Industry10.01
Upside+11.35%
P/B
CTNM2.18
Industry5.15
Upside-57.66%